-
2024-510579-40-00
9
2020-10-07
Rhabdoyosarcoma
-
2024-518077-34-00
5
2020-09-30
locally advanced rectal cancer
-
2024-514014-13-00
9
2020-09-02
female and male adult patients with acute myeloid leukemia
-
2023-505737-26-00
5
2020-07-22
Steroid refractory Acute Graft versus host Disease
-
2022-501456-28-00
5
2020-07-20
atypical teratoid/rhabdoid tumours (ATRT)
-
2024-514494-21-00
4
2020-05-13
autoimmune encephalitis
-
2024-516741-39-00
6
2020-01-14
Haemophilia A
-
2024-510964-21-00
9
2019-09-12
Glioblastoma
-
2023-508101-24-00
5
2019-08-01
Lymphoblastic lymphoma
-
2023-508302-24-00
4
2019-05-07
Locally Advanced/Metastatic Urothelial Cancer
-
2023-504880-18-00
9
2018-04-18
Neuroblastoma (NBL)
-
2023-506987-15-00
9
2016-11-17
Metastatic Castration-Resistant Prostate Cancer
-
2024-512222-28-00
10
2015-06-02
Newly diagnosed with an intracranial or spinal ependymoma (all WHO gra
-
2022-501257-36-00
9
2015-03-19
Treatment of advanced melanoma, or advanced, relapsed or
refractory PD
-
2025-521067-13-00
5
2026-04-24
Atherosclerotic Cardiovascular Disease (ASCVD)
-
2025-521912-21-00
4
2026-01-26
Cardiovascular risk reduction in participants with elevated Lp(a)
-
2025-521624-30-00
4
2026-01-08
Atopic dermatitis
-
2023-506146-23-00
4
2025-11-17
Non-Muscle-Invasive Urothelial Carcinoma (NMIBC) of the Bladder
-
2023-508988-73-00
5
2025-10-29
Cytomegalovirus (CMV) infection in children and adolescents who have r
-
2025-520521-21-00
5
2025-09-02
Hyperlipidemia
-
2024-516473-72-00
5
2025-07-31
Multifocal Motor Neuropathy
-
2024-520109-37-00
4
2025-07-09
PMM2-CDG
-
2024-515523-11-00
5
2025-06-09
Chronic Weight Management
-
2024-515524-36-00
5
2025-05-30
Chronic Weight Management